Business

OTC Markets Group Welcomes Newly Verified OTCQB Companies – December 1

OTC Markets Group Welcomes Newly Verified OTCQB Companies – December 1.

articleCnbx Pharmaceuticals Inc.December 1, 20165/company/cannabics-pharmaceuticals-inc/news/otc-markets-group-welcomes-newly-verified-otcqb-companies-december-1
OTC Markets Group Welcomes Newly Verified OTCQB Companies – December 1

About this update from Cnbx Pharmaceuticals Inc.

[{"type":"text","content":"OTC Markets Group Inc. (OTCQX: OTCM), operator of financial markets for 10,000 U.S. and global securities, today announced the following companies are verified for trading on the OTCQB® Venture Market:Avalon GloboCare Corp. (OTCQB: AVCO) – Avalon Globocare Corp. (\"Avalon\") is a provider of outsourced, customized international healthcare services to the rapidly changing health care industry primarily focused in the Peoples Republic of China. Avalon is also pursuing the provision of these services in the United States as well as certain strategic partnerships and property ownership and management.Cannabics Pharmaceuticals Inc. (OTCQB: CNBX) – Cannabics Pharmaceuticals Inc., a U.S based public company, is dedicated to the development of Personalized Anti-Cancer treatments. The Company's scientific focus is on harnessing the proven therapeutic properties of natural Cannabinoids. Cannabics' vision is to create tailored therapies for cancer patients, utilizing advanced HTS technology and personalized bioinformatics tools. The Company's R&D is based in Israel, where it is fully licensed by the Ministry of Health and involves both scientific and academic research as well as current ongoing medical clinical studies which are registered with the US NIH. Cannabics Pharmaceuticals is dedicated to the development of advanced cannabinoid-based treatments and therapies. The Company's main focus is the development of novel therapies and biotechnological tools aimed to providing relief from diverse ailments and treat human malignancies. These advanced tools include novel delivery systems, personalized medicine diagnostics and therapies based on cannabinoid compounds. Cannabics' research is devoted to the discovery of cannabinoid compounds targeted to specific cancers based on cutting edge High Through-output Screening and bioinformatic tools.Margaux Resources Ltd. (TSX-V: MRL; OTCQB: MARFF) – Margaux Resources Ltd. is a mineral exploration company focused on the exploration and development of the previously producing Jersey-Emerald property, located in southeastern British Columbia, Canada.Towerstream Corp. (OTCQB: TWER) – Towerstream is a Fixed Wireless Internet Service Provider (ISP). Towerstream delivers, as an alternative to fiber, advanced, high-speed fixed wireless Internet access to businesses across 12 majo...

More updates from Cnbx Pharmaceuticals Inc.